Clinical Trial Update: Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial [Phase 3]

View source ↗

Summary

An update on a Phase 3 pilot randomized controlled trial evaluating aspirin in subclinical coronary artery disease. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Subclinical Atherosclerotic Cardiovascular Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Coronary Artery Disease, Subclinical Atherosclerotic Cardiovascular Disease | Phase 3 | Status: NOT_YET_RECRUITING